Michael J. Gaunt PharmD
Michael J. Gaunt, PharmD is a Medication Safety Analyst and Editor at the Institute for Safe Medication Practices (ISMP), which he joined in 2004. Michael co-coordinates the ISMP National Medication Errors Reporting Program (ISMP MERP) and the ISMP National Vaccine Errors Reporting Program (ISMP VERP). In this role, he works collaboratively with the US Food and Drug Administration (FDA) to advocate for nomenclature, packaging, and labeling improvements to reduce the risk of error. He participates in on-site risk assessments in health care systems, particularly their ambulatory care areas, and community pharmacies to assess risks and identify opportunities to improve safety and reliability. Michael also serves as the editor of the monthly ISMP Medication Safety Alert!® Community/Ambulatory Care newsletter.
Michael is one of the project leaders for the Hospital and Healthsystem Association of Pennsylvania (HAP) Hospital Improvement Innovation Network’s (HIIN) Adverse Drug Event (ADE) Project, a collaborative project engaging healthcare organizations to improve reliability and reduce and prevent patient harm from the use of anticoagulants, insulins, and opioids. He also represents ISMP at several organizations and partnerships, including the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), the Centers for Disease Control and Prevention (CDC) PROTECT Initiative, and the Partnership for Health IT Patient Safety. Michael has made contributions to medication and health information technology safety science as a member of various grant-funded research teams. He has published articles in the patient safety and pharmacy literature, including a monthly column in Pharmacy Times.
Michael received a Bachelor of Arts in History from the University of Notre Dame and a Doctor of Pharmacy with a Certificate in Drug Safety from Temple University School of Pharmacy.
View Michael’s LinkedIn profile here.